secwatch / observer

8-K filed February 20, 2026, 6:59 PM ET ticker ACAA CIK 0002096900

other material confidence high sentiment positive materiality 0.75

Averin Capital Acquisition Corp. prices and closes $250M IPO of 25M units at $10.00

Averin Capital Acquisition Corp.

IPO of 25,000,000 units at $10.00 per unit, gross proceeds $250,000,000; units began trading Feb 19 under ACAAU.
Private placement of 200,000 units at $10.00 to sponsor Averin Capital Acquisition Sponsor LLC.
$250M placed in trust account; trust funds available only upon completion of a business combination or liquidation within 24 months.
Ulrik Schulze, Graeme Bell, and Mary T. Szela appointed to board; committee assignments set.
Underwriters granted 45-day option to purchase up to 3,750,000 additional units to cover over-allotments.

item 1.01 item 3.02 item 5.02 item 5.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-018849
form_type: 8-K
ticker: ACAA
cik: 0002096900
company_name: Averin Capital Acquisition Corp.
filed_at: 2026-02-20T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.251835+00:00
generated_at: 2026-05-16T01:34:54.630906+00:00
sec_items: ["1.01", "3.02", "5.02", "5.03", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-018849
json_url: https://secwatch.observer/filing/0001213900-26-018849.json
markdown_url: https://secwatch.observer/filing/0001213900-26-018849.md
text_url: https://secwatch.observer/filing/0001213900-26-018849.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2096900/000121390026018849/0001213900-26-018849-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2096900/000121390026018849/ea0277795-8k_averin.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

19a6872759ecea0cd3e43290d7ee423eb40705bb

Averin Capital Acquisition Corp. entered into Letter Agreement with officers, directors and Sponsor valued at Letter agreement among Company, officers, directors and Sponsor (effective 2026-02-18).

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

22485d2a308e075403d44fedfb4d317d44bd75a4

Averin Capital Acquisition Corp. entered into Underwriting Agreement with Deutsche Bank Securities Inc. valued at IPO of 25,000,000 units at $10.00 per unit, $250,000,000 gross proceeds (effective 2026-02-18).

An Underwriting Agreement, dated February 18, 2026 by and between the Company and Deutsche Bank Securities Inc., as representative of the several underwriters

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

2f80409335a9600fdfb44eef7a0c5a1c168f7e62

Averin Capital Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Trust agreement related to IPO proceeds (effective 2026-02-18).

An Investment Management Trust Agreement, dated February 18, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

7065cd75a50a630946b39e7cf4f847459623a18d

Averin Capital Acquisition Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at Each whole Warrant entitling holder to purchase one Class A Ordinary Share for $11.50 per share (effective 2026-02-18).

A Warrant Agreement, dated February 18, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

760000b38fd9319bca60faabbd76cb81b132e901

Averin Capital Acquisition Corp. entered into Registration Rights Agreement with certain security holders valued at Registration rights for security holders (effective 2026-02-18).

A Registration Rights Agreement, dated February 18, 2026, by and among the Company and certain security holders

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

A Share Rights Agreement, dated May 26, 2026, by and between the Company and Odyssey Transfer and Trust Company, as rights agent

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

Private Units Subscription Agreement, dated May 6, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference

Filing page SEC filing

CLRB

Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data

Cellectar Biosciences, Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).

Filing page SEC filing

XRN

Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP

Chiron Real Estate Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.

Filing page SEC filing

PBT

Court approves trust indenture amendments eliminating 75% supermajority requirement

PERMIAN BASIN ROYALTY TRUST May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.

Filing page SEC filing

NKTR

Nektar enters $150M ATM equity agreement; appoints Linda Rubinstein as interim CFO

NEKTAR THERAPEUTICS May 8, 2026, 7:59 PM ET other_material Items 1.01, 5.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 5.02, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

On May 8, 2026, Nektar Therapeutics (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Guggenheim Securities, LLC (“Guggenheim Securities”) and H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company may offer and sell, from time to time in its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”) having an aggregate offering price of up to $150,000,000 (the “Shares”), through Guggenheim Securities and Wainwright as its sales agents.

Filing page SEC filing

QUCY

Quantum Cyber increases equity distribution capacity to $100M; CFO Caragol moves to consulting role

Quantum Cyber N.V. May 8, 2026, 7:59 PM ET other_material Items 1.01, 5.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 5.02, 9.01 same event type: other_material similar materiality

This filing

A Letter Agreement, dated February 18, 2026, by and among the Company, its officers, its directors and the Sponsor

Comparable filing

On May 4, 2026, Quantum Cyber N.V. (the “Company”) entered into that certain Amendment No. 1 to Equity Distribution Agreement (“Amendment No. 1”) with Maxim Group LLC (the “Sales Agent”), which amends that certain Equity Distribution Agreement, dated as of October 3, 2025, between the Company and Sales Agent (the “Original Agreement” and, together with Amendment No. 1, the “Sales Agreement”).

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-26-018849

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.